Cargando…

Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)

BACKGROUND: Spinal Muscular Atrophy (SMA), a leading genetic cause of death in infants, is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. While early diagnosis of SMA is critical to modifying disease progression and improving outcomes, serious...

Descripción completa

Detalles Bibliográficos
Autores principales: Curry, Mary, Cruz, Rosángel, Belter, Lisa, Schroth, Mary, Lenz, Megan, Jarecki, Jill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127310/
https://www.ncbi.nlm.nih.gov/pubmed/34001052
http://dx.doi.org/10.1186/s12887-021-02692-2
_version_ 1783693931402231808
author Curry, Mary
Cruz, Rosángel
Belter, Lisa
Schroth, Mary
Lenz, Megan
Jarecki, Jill
author_facet Curry, Mary
Cruz, Rosángel
Belter, Lisa
Schroth, Mary
Lenz, Megan
Jarecki, Jill
author_sort Curry, Mary
collection PubMed
description BACKGROUND: Spinal Muscular Atrophy (SMA), a leading genetic cause of death in infants, is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. While early diagnosis of SMA is critical to modifying disease progression and improving outcomes, serious diagnostic delays persist. There is a need to improve SMA awareness, screening, and referral patterns. METHODS: Two online surveys, developed by Cure SMA for general pediatricians, were distributed by Medscape Education via email (September 2018, n = 300, December 2019, n = 600). The surveys asked about adherence to the American Academy of Pediatrics (AAP) developmental screening and surveillance guidelines, comfort with identification of early signs of neuromuscular disease (NMD), familiarity with SMA, and barriers to timely referral. RESULTS: In 2018, 70.3% of survey respondents indicated comfort in identifying early signs of NMD and 67.3% noted familiarity with SMA. 52.7% correctly indicated the need for genetic testing to make a definitive diagnosis of SMA, 74.0% meet or exceed developmental screening recommendations, and 52.0% said they would immediately refer to a specialist. In 2019, with a larger sample, 73.0% adhere to developmental screening guidelines, and awareness of the genetic testing requirement for SMA was significantly lower by 7.7% (p < 0.03). Specialist wait times emerged as a barrier to referral, with 64.2% of respondents citing wait times of 1–6 months. CONCLUSIONS: Many pediatricians underutilize developmental screening tools and lack familiarity with diagnostic requirements for SMA. Continuing efforts to expand awareness and remove barriers to timely referral to SMA specialists, including reducing appointment wait times, are needed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-021-02692-2.
format Online
Article
Text
id pubmed-8127310
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81273102021-05-18 Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA) Curry, Mary Cruz, Rosángel Belter, Lisa Schroth, Mary Lenz, Megan Jarecki, Jill BMC Pediatr Research Article BACKGROUND: Spinal Muscular Atrophy (SMA), a leading genetic cause of death in infants, is an autosomal recessive neuromuscular disease characterized by progressive muscle weakness and atrophy. While early diagnosis of SMA is critical to modifying disease progression and improving outcomes, serious diagnostic delays persist. There is a need to improve SMA awareness, screening, and referral patterns. METHODS: Two online surveys, developed by Cure SMA for general pediatricians, were distributed by Medscape Education via email (September 2018, n = 300, December 2019, n = 600). The surveys asked about adherence to the American Academy of Pediatrics (AAP) developmental screening and surveillance guidelines, comfort with identification of early signs of neuromuscular disease (NMD), familiarity with SMA, and barriers to timely referral. RESULTS: In 2018, 70.3% of survey respondents indicated comfort in identifying early signs of NMD and 67.3% noted familiarity with SMA. 52.7% correctly indicated the need for genetic testing to make a definitive diagnosis of SMA, 74.0% meet or exceed developmental screening recommendations, and 52.0% said they would immediately refer to a specialist. In 2019, with a larger sample, 73.0% adhere to developmental screening guidelines, and awareness of the genetic testing requirement for SMA was significantly lower by 7.7% (p < 0.03). Specialist wait times emerged as a barrier to referral, with 64.2% of respondents citing wait times of 1–6 months. CONCLUSIONS: Many pediatricians underutilize developmental screening tools and lack familiarity with diagnostic requirements for SMA. Continuing efforts to expand awareness and remove barriers to timely referral to SMA specialists, including reducing appointment wait times, are needed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12887-021-02692-2. BioMed Central 2021-05-17 /pmc/articles/PMC8127310/ /pubmed/34001052 http://dx.doi.org/10.1186/s12887-021-02692-2 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Curry, Mary
Cruz, Rosángel
Belter, Lisa
Schroth, Mary
Lenz, Megan
Jarecki, Jill
Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)
title Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)
title_full Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)
title_fullStr Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)
title_full_unstemmed Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)
title_short Awareness screening and referral patterns among pediatricians in the United States related to early clinical features of spinal muscular atrophy (SMA)
title_sort awareness screening and referral patterns among pediatricians in the united states related to early clinical features of spinal muscular atrophy (sma)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127310/
https://www.ncbi.nlm.nih.gov/pubmed/34001052
http://dx.doi.org/10.1186/s12887-021-02692-2
work_keys_str_mv AT currymary awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma
AT cruzrosangel awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma
AT belterlisa awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma
AT schrothmary awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma
AT lenzmegan awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma
AT jareckijill awarenessscreeningandreferralpatternsamongpediatriciansintheunitedstatesrelatedtoearlyclinicalfeaturesofspinalmuscularatrophysma